Surfactant treatment in preterm infants and term newborns with (acute respiratory distress
syndrome) ARDS-like severe respiratory failure has become part of an individualized …

Objectives: This study aimed to compare the efficacy of surfactant administration by
laryngeal mask airway (LMA) and endotracheal intubation in the management of respiratory …

Background: Surfactant replacement therapy is crucial in the management of respiratory
distress syndrome (RDS) in preterm infants. Classic strategies of surfactant administration …

OBJECTIVE: We studied the efficacy and safety of electively providing surfactant to preterm
infants with mild to moderate respiratory distress syndrome (RDS) not requiring mechanical …

Endotracheal bolus application of natural surfactant has been shown to be an effective
treatment for idiopathic respiratory distress syndrome (IRDS), especially in premature …

Background: Pulmonary inflammation plays a critical role in the pathogenesis of respiratory
distress syndrome. The aim of this study was to compare the effectiveness of intratracheal …

Objectives To compare the clinical efficacy and the cost of treatment between the newborns
who received either a natural or a protein-free synthetic surfactant for respiratory distress …

Respiratory distress syndrome (RDS) is the major cause of respiratory failure in preterm
infants due to immature lung development and surfactant deficiency. Although the concepts …

新生儿急性呼吸窘迫综合征 (ARDS) 是新生儿常见的临床危重症, 是新生儿致死,
致残的主要原因之一. 新生儿 ARDS 病因及发病机制复杂, 与各种病理因素导致的继发性肺表面 …

Background: It is suggested that there may be expanded use of surfactant replacement for
the neonatal diseases such as meconium aspiration syndrome (MAS), pneumonia and …